(NEW YORK)–Freedom Leaf, Inc. (OTCMKTS:FRLF), a leading go-to resource in the cannabis, medical marijuana, and industrial hemp industry, reported a sharp increase in fiscal year revenues based on growing magazine subscriptions and licensing fees.
For the year ended June 30, 2017, the Company reported total revenues of $817,457, as compared to $118,473 for the same period in 2016. The increase in revenue was attributable to increased sales related to increased magazine subscriptions and licensing fees.
Freedom Leaf, Inc.’s flagship publication is Freedom Leaf Magazine, “The Good News in Marijuana Reform”. The company produces a portfolio of news, print and digital multi-media verticals, websites, blogs and web advertising, for the ever-changing emerging cannabis, medical marijuana and industrial hemp industry.
Think of it as a version of the popularly known High Times Magazine.
Freedom Leaf has published and circulated hundreds of thousands of copies of their 27 editions in 38 states with the assistance of over 160 activist marketers. Freedom Leaf magazine, “The Good News in Marijuana Reform,” reports on arts, fashion, and lifestyle, all of the elements of the burgeoning cannabis movements. Freedom Leaf magazine provides activists, consumers, patients and entrepreneurs with a means to stay informed on the emerging industry’s most cutting edge marijuana-related information, innovations and legislation.
This magazine gives FRLF an ever growing network of industry players and connections that can be marketed to other cannabis companies, or be used for their our operational businesses.
Note: Freedom Leaf, Inc. does not handle, grow, sell, or dispense marijuana, and their European activities are in full compliance with relevant EU laws.
This is very key point for investors to look at when investing into a marijuana stock as this places FRLF on the safer side of the investment spectrum.
Sell the Growers, Buy Medical
Just recently, Ludlow Research issued a note to their subscribers regarding investors wanting to invest in marijuana stocks that they may want to sell the growers, dispensaries, and recreational plays, and focus investment capital more in a diversified basket of stocks focused strictly on medical research and non-recreational use side due to potential regulatory risks.
For this reason Ludlow Research has initiated coverage on FRLF based on their strict focus on non-psychoactive cannabis operations, growing revenues, and launch of the Hempology and Leafceuticals operations, with a ‘speculative’ short-term target of around $0.10+ per share.
This would place FRLF with similar medical and non-recreational marijuana plays such as OWC Pharmaceutical Research Corp (OTC:OWCP), India Globalization Capital, Inc. (NYSE: IGC), 22nd Century Group, Inc. (NYSE:XXII), International Endeavor Corp. (OTC:IDVV), or Medical Marijuana Inc. (OTC:MJNA) to name just a few.
About Freedom Leaf™
Freedom Leaf, Inc., The Marijuana Legalization Company™, is a fully reporting and audited, publicly traded company trading under the symbol (OTCQB: FRLF). Freedom Leaf, Inc. is a leading go-to resource in the cannabis, medical marijuana, and industrial hemp industry. It is involved in mergers and acquisitions and business consulting in the marijuana industry, including incubation/acceleration and spin offs of new marijuana/hemp related companies. www.FreedomLeafInc.com